Verve Therapeutics, Inc.

NASDAQ
VERV
Stock
Yield per half year: -24.55%
Dividend yield: 0%
Sector: Healthcare

Reporting Verve Therapeutics, Inc.

Capitalization

IFRS
Reporting Annual Quarterly
2019 2020 2021 2022 2023 2024 LTM 5 year average CAGR 5
Капитализация, млрд $
1.43 1.27 1.19 0.8947 1.30 -5.94
Выручка, млрд $
0.0019 0.0118 0.0323 0.0323 0.0153 157.13
Чистая прибыль, млрд $
-0.019 -0.046 -0.12 -0.1574 -0.2001 -0.1987 -0.1987 -0.1444 33.99
EV, млрд $
-0.003 -0.009 1.04 1.01 0.8192 0.3753 0.3753 0.6471 -310.88
EBIT, млрд $
-0.0136 -0.0406 -0.0871 -0.1696 -0.2231 -0.2287 -0.2287 -0.1498 41.30
EBITDA, млрд $
-0.0135 -0.0393 -0.0708 -0.1629 -0.2177 -0.2219 -0.2219 -0.1425 41.37
OIBDA, млрд $
-0.0344 -0.054 -0.1712 -0.2407 -0.2519 -0.2519 -0.1504 48.91
Баланс стоимость, млрд $
-0.0208 -0.0665 -0.1869 0.5509 0.5995 0.4934 0.4934 0.2781 -249.31
FCF, млрд $
-0.009 -0.039 -0.082 -0.1356 -0.1588 -0.1614 -0.1614 -0.1154 32.85
Операционный денежный поток, млрд $
-0.0074 -0.0353 -0.0779 -0.1223 -0.1495 -0.1577 -0.1577 -0.1085 34.90
Операционная прибыль, млрд $
-0.014 -0.041 -0.087 -0.1657 -0.2231 -0.2287 -0.2287 -0.1491 41.03
Операционные расходы, млрд $
0.0136 0.0406 0.0871 0.1676 0.2349 0.261 0.261 0.1582 45.09
CAPEX, млрд $
0.002 0.003 0.004 0.0132 0.0093 0.0037 0.0037 0.0066 4.28


Balance sheet

IFRS
Reporting Annual Quarterly
2019 2020 2021 2022 2023 2024 LTM 5 year average CAGR 5
Наличность, млрд $
0.0188 0.0721 0.3892 0.1154 0.2062 0.1726 0.1726 0.1911 19.08
Short Term Investments $
0.0158 0.0631 0.2961 0.4394 0.4178 0.3517 0.3517 0.3136 41.00
Total Receivables $
0.0027 0.001 0.0059 0.0033 0.0033 0.0032 5.14
Total Current Assets $
0.0191 0.074 0.3671 0.5632 0.6379 0.5428 0.5428 0.4370 48.96
Чистые активы, млрд $
-0.0196 -0.0639 0.3574 0.0188 0.5509 0.0188 0.1687 -294.88
Активы, млрд $
0.0216 0.0784 0.3841 0.6792 0.7527 0.6474 0.6474 0.5084 52.54
Short Term Debt $
0.0000 -0.0001 0.002 0.0238 0.0102 0.0209 0.0209 0.0114 -391.09
Задолженность, млрд $
0.0412 0.1423 0.0268 0.1283 0.1532 0.154 0.154 0.1209 1.59
Чистый долг, млрд $
-0.003 -0.009 -0.0624 -0.0335 -0.1313 -0.1026 -0.1026 -0.0678 62.70
Долг, млрд $
0.0351 0.1252 0.0025 0.0819 0.0749 0.07 0.07 0.0709 -10.98
Interest income $
0.000278 0.000162 0.0001 0.0069 0.0019 123.20
Расходы на обслуживание долга $
0.0332 0.0084 0.009 0.0084 0.0169 -35.28
Чист. проц. доходы, млрд $
0.000278 0.000162 0.0001 0.0069 0.0023 0.0023 0.0019 52.59
Амортизация, млрд $
0.000106 0.0013 0.0015 0.0067 0.0055 0.0068 0.0068 0.0044 39.22
Себестоимость, млрд $
0.000106 0.0013 0.0034 0.0067 0.0055 0.0068 0.0068 0.0047 39.22
Товарно материальные запасы $
0 0 0


Share

IFRS
Reporting Annual Quarterly
2019 2020 2021 2022 2023 2024 2025 LTM 5 year average CAGR 5
EPS -1.09 -2.58 -4.48 -2.91 -3.12 -2.35 -2.35 -3.0880 -1.85
Цена акции ао 30.01 20 13.94 5.64 6.08 6.08 15.13 -27.33
Число акций ао, млн 17 17 26 54.02 64.18 84.72 84.72 49.18 37.88
FCF/акцию -0.3187 -2.18 -4.64 -2.51 -2.47 -1.91 -1.91 -2.7420 -2.61


Efficiency

IFRS
Reporting Annual Quarterly
2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % 98.69 109.52 -82 -34.66 -34.78 -36.36 -36.36 17.60 -15.6560 -180.21
ROA, % -89.14 -91.35 -52.02 -29.6 -27.94 -28.39 -28.39 5.71 -45.8600 -20.84
ROIC, % -80.92 -106.44 17.65 -80.9200 0.00
ROS, % -8108.55 -1701.55 -614.59 -614.59 -614.59 13.36 -2759.8200 -47.53
ROCE, % -75.4 -57.14 -24.05 -26.33 -31.18 -37.83 -46.34 -46.34 29.73 -33.1460 14.02
Ebit margin, % -8737.45 -1897.64 -707.23 -707.23 -707.23 18.53 -3012.3875 -46.66
Рентаб EBITDA, % 0 -8391.71 -1851.24 -686.34 -686.34 -686.34 26.10 -2903.9075 -46.52
Чистая рентаб, % 0 -8108.55 -1701.55 -614.59 -614.59 13.36 -3474.8967 -57.68
Operation Margin, % -8536.17 -1897.64 -707.23 -707.23 -707.23 16.64 -2962.0675 -46.35
Доходность FCF, % -3.44 -8.59 -14.1 -8.7100 60.04


Coefficients

IFRS
Reporting Annual Quarterly
2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/E
-20.15 6.24 -5.63 6.24 69.28 -6.5133 -34.63
P/BV
4.6 1.9 1.59 0.9685 0.9685 8.88 2.26 -32.26
P/S
538.57 80.83 14.78 14.78 8.07 211.39 -69.84
P/FCF
-29.07 -11.64 -6.6 -5.63 -5.54 -5.54 8.97 -11.6960 -28.22
E/P
-0.0496 -0.0997 -0.1776 -0.2236 -0.2221 -0.2221 0.03 -0.1545 34.96
EV/EBIT
-2.35 -2.86 -19.33 -5.97 -3.67 -1.64 -1.64 -1.64 88.62 -6.4500 -38.94
EV/EBITDA
0.2206 0.2288 -14.67 -6.21 -3.76 -1.69 -1.69 53.93 -5.2202 -249.17
EV/S
521.31 69.67 11.61 11.61 11.61 8.39 153.55 -61.37
EV/FCF
-3.45 -3 -20.46 -7.46 -5.16 -2.32 -2.32 -2.32 21.66 -7.5440 -35.30
Debt/EBITDA
-2.59 -3.18 -0.0229 -0.5029 -0.3441 -0.3154 -0.3154 -0.3154 2.61 -0.3001 68.97
Netdebt/Ebitda
-2.37 -2.96 0.7293 0.2056 0.6031 0.4623 0.4623 0.4623 0.49 0.4925 -8.71
Debt/Ratio
1.62 1.6 0.0051 0.1206 0.0995 0.1081 0.1081 0.1081 0.24 0.0883 84.18
Debt/Equity
-1.79 -1.96 0.0055 0.1487 0.1249 0.1418 0.3121 0.3121 2.82 0.1466 124.28
Debt/Net Income
-1.84 -2.75 -0.0165 -0.5205 -0.3744 -0.3522 -0.3522 -0.3522 10.75 -0.3232 84.44
PEG
6.59 6.59 -67.62 6.59 0.00
Бета
-0.4956 4.63 1.27 1.58 -0.167 -0.167 -0.68 1.36 -19.55
Индекс Альтмана
19.04 6.38 0.8566 0.9246 0.9683 0.9683 12.59 5.63 -44.89


Dividends

IFRS
Reporting Annual
2021 2022 2023 LTM Industry average 5 year average CAGR 5
Дивиденд
0
Див доход, ао, %
0 0 0 0 1.71
Дивиденды / прибыль, %
0 0 0 0 155.02


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual Quarterly
2019 2020 2022 2023 2024 LTM CAGR 5
Всего задолженность
0.0036 0.0073 42.40
Персонал, чел
113 204 255 31.17
CAPEX/Выручка, %
681.71 78.95 11.56 11.56 -74.31